- Home
- ARTW vs CLDI Comparison
ARTW vs CLDI Comparison
Compare ARTW & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- CLDI
- Stock Information
- Founded
- ARTW 1956
- CLDI 2014
- Country
- ARTW United States
- CLDI United States
- Employees
- ARTW N/A
- CLDI N/A
- Industry
- ARTW Industrial Machinery/Components
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARTW Industrials
- CLDI Health Care
- Exchange
- ARTW Nasdaq
- CLDI Nasdaq
- Market Cap
- ARTW 9.3M
- CLDI 10.2M
- IPO Year
- ARTW N/A
- CLDI N/A
- Fundamental
- Price
- ARTW $3.04
- CLDI $0.73
- Analyst Decision
- ARTW
- CLDI
- Analyst Count
- ARTW 0
- CLDI 0
- Target Price
- ARTW N/A
- CLDI N/A
- AVG Volume (30 Days)
- ARTW 67.4K
- CLDI 41.8M
- Earning Date
- ARTW 07-10-2025
- CLDI 08-12-2025
- Dividend Yield
- ARTW N/A
- CLDI N/A
- EPS Growth
- ARTW N/A
- CLDI N/A
- EPS
- ARTW 0.44
- CLDI N/A
- Revenue
- ARTW $23,523,353.00
- CLDI N/A
- Revenue This Year
- ARTW N/A
- CLDI N/A
- Revenue Next Year
- ARTW N/A
- CLDI N/A
- P/E Ratio
- ARTW $8.75
- CLDI N/A
- Revenue Growth
- ARTW N/A
- CLDI N/A
- 52 Week Low
- ARTW $1.40
- CLDI $0.20
- 52 Week High
- ARTW $4.15
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- ARTW 72.27
- CLDI 61.42
- Support Level
- ARTW $2.55
- CLDI $0.47
- Resistance Level
- ARTW $3.02
- CLDI $0.82
- Average True Range (ATR)
- ARTW 0.20
- CLDI 0.19
- MACD
- ARTW 0.05
- CLDI 0.02
- Stochastic Oscillator
- ARTW 99.01
- CLDI 36.03
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.